Propensity for biofilm formation by clinical isolates from urinary tract infections: Developing a multifactorial predictive model to improve antibiotherapy

Journal of Medical Microbiology

Volumn 63, Issue PART 3, 2014, Pages 471-477

  Alves, Maria José ^a,b,c   Barreira, João C M ^c,d   Carvalho, Inês ^c   Trinta, Luis ^c   Perreira, Liliana ^c   Ferreira, Isabel C F R ^c   Pintado, Manuela ^a  

^a UNIVERSIDADE CATÓLICA PORTUGUESA   (Portugal)

^b Centro Hospitalar de Trás os Montes   (Portugal)

^c INSTITUTO POLITÉCNICO DE BRAGANÇA   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CARBAPENEM DERIVATIVE; CEFALOTIN; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BIOFILM; BIOFILM PRODUCING BACTERIA; BLADDER CATHETERIZATION; CITROBACTER FREUNDII; CLINICAL ARTICLE; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; FEMALE; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; MORGANELLA MORGANII; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; URINARY CATHETER; URINARY TRACT INFECTION; VERY ELDERLY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BIOFILMS; CHILD; CHILD, PRESCHOOL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84896725613     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.071746-0     Document Type: Article

References (36)

1. Al-Mathkhury, H. J. F., Ali, A. S. & Ghafil, J. A. (2011). Antagonistic effect of bacteriocin against urinary catheter associated Pseudomonas aeruginosa biofilm. N Am J Med Sci 3, 367-370.
2. Bonkat, G., Widmer, A. F., Rieken, M., van der Merwe, A., Braissant, O., Muller, G., Wyler, S., Frei, R., Gasser, T. C. & Bachmann, A. (2013). Microbial biofilm formation and catheter-associated bacteriuria in patients with suprapubic catheterisation. World J Urol 31, 565-571.
3. Christensen, G. D., Simpson, W. A., Bisno, A. L. & Beachey, E. H. (1982). Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun 37, 318-326.
4. Christensen, G. D., Simpson, W. A., Younger, J. J., Baddour, L. M., Barrett, F. F., Melton, D. M. & Beachey, E. H. (1985). Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22, 996-1006.
5. CLSI (2008) Performance Standards for Antimicrobial Susceptibility Testing; M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute.
6. Comité de l'Antibiogramme de la Société Franç aise de Microbiologie (2008). Paris: Société Française de Microbiologie.
7. Dohnt, K., Sauer, M., Muller, M., Atallah, K., Weidemann, M., Gronemeyer, P., Rasch, D., Tielen, P. & Krull, R. (2011). An in vitro urinary tract catheter system to investigate biofilm development in catheter-associated urinary tract infections. J Microbiol Methods 87, 302-308.
8. Donlan, R. M. & Costerton, J. W. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15, 167-193.
9. Eshwarappa, M., Dosegowda, R., Aprameya, I. V., Khan, M. W., Kumar, P. S. & Kempegowda, P. (2011). Clinico-microbiological profile of urinary tract infection in south India. Indian J Nephrol 21, 30-36.
10. Foxman, B., Wu, J., Farrer, E. C., Goldberg, D. E., Younger, J. G. & Xi, C. (2012). Early development of bacterial community diversity in emergently placed urinary catheters. BMC Res Notes 5, 332.
11. Guggenbichler, J. P., Assadian, O., Boeswald, M. & Kramer, A. (2011). Incidence and clinical implication of nosocomial infections associated with implantable biomaterials catheters, ventilator-associated pneumonia, urinary tract infections. GMS Krankenhhyg Interdiszip 6, 18.
12. Guiton, P. S., Hung, C. S., Hancock, L. E., Caparon, M. G. & Hultgren, S. J. (2010). Enterococcal biofilm formation and virulence in an optimized murine model of foreign body-associated urinary tract infections. Infect Immun 78, 4166-4175.
13. Hassan, A., Usman, J., Kaleem, F., Omair, M., Khalid, A. & Iqbal, M. (2011). Evaluation of different detection methods of biofilm formation in the clinical isolates. Braz J Infect Dis 15, 305-311.
14. 2+-, and HEPES-treated Pseudomonas aeruginosa biofilms. Can J Microbiol 38, 1214-1218.
15. Lynch, A. S. & Robertson, G. T. (2008). Bacterial infections and fungal biofilm infections. Annu Rev Med 59, 415-428.
16. National Nosocomial Infections Surveillance System (2002). National Nosocomial Infections Surveillance System Report (NNIS), data summary from January 1992 through June. Am J Infect Control 30, 458-475.
17. Niveditha, S., Pramodhini, S., Umadevi, S., Kumar, S. & Stephen, S. (2012). The isolation and the biofilm formation of uropathogens in the patients with catheter associated urinary tract infections (UTIs). J Clin Diagn Res 6, 1478-1482.
18. Ponnusamy, P., Natarajan, V. & Sevanan, M. (2012). In vitro biofilm formation by uropathogenic Escherichia coli and their antimicrobial susceptibility pattern. Asian Pacific J Trop Med 5, 210-213.
19. PPCIRA (2013). Programa de Prevenção e Controlo de Infeções e de Resistência aos Antimicrobianos, Orientações Programáticas. Dirȩão Geral de Saúde, Ministério da Saúde, Lisboa, Portugal.
20. Regev-Shoshani, G., Ko, M., Crowe, A. & Av-Gay, Y. (2011). Comparative efficacy of commercially available and emerging antimicrobial urinary catheters against bacteriuria caused by E. coli in vitro. Urology 78, 334-339.
21. Reid, G., Charbonneau-Smith, R., Lam, D., Kang, Y. S., Lacerte, M. & Hayes, K. C. (1992). Bacterial biofilm formation in the urinary bladder of spinal cord injured patients. Paraplegia 30, 711-717.
22. Ronald, A. (2002). The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113 (Suppl. 1A), 14S-19S.
23. Sanchez, C. J., Jr, Mende, K., Beckius, M. L., Akers, K. S., Romano, D. R., Wenke, J. C. & Murray, C. K. (2013). Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect Dis 13, 47.
24. Singhai, M., Malik, A., Shahid, M., Malik, M. A. & Goyal, R. (2012). A study on device-related infections with special reference to biofilm production and antibiotic resistance. J Global Infect Dis 4, 193-198.
25. Soto, S. M., Smithson, A., Martinez, J. A., Horcajada, J. P., Mensa, J. & Vila, J. (2007). Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol 177, 365-368.
26. Stahlhut, S. G., Struve, C., Krogfelt, K. A. & Reisner, A. (2012). Biofilm formation of Klebsiella pneumoniae on urethral catheters requires either type 1 or type 3 fimbriae. FEMS Immunol Med Microbiol 65, 350-359.
27. Stickler, D. J. (1996). Bacterial biofilms and the encrustation of urethral catheters. Biofouling 9, 293-305.
28. Stickler, D. J., King, J., Nettleton, J. & Winters, C. (1993a). The structure of urinary catheter encrusting bacterial biofilms. Cells Materials 3, 315-319.
29. Stickler, D., Ganderton, L., King, J., Nettleton, J. & Winters, C. (1993b). Proteus mirabilis biofilms and the encrustation of urethral catheters. Urol Res 21, 407-411.
30. Suci, P. A., Mittelman, M. W., Yu, F. P. & Geesey, G. G. (1994). Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 38, 2125-2133.
31. Tamilvanan, S., Venkateshan, N. & Ludwig, A. (2008). The potential of lipidand polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections. J Control Release 128, 2-22.
32. Tenke, P., Kovacs, B., Jackel, M. & Nagy, E. (2006). The role of biofilm infection in urology. World J Urol 24, 13-20.
33. Tenke, P., Koves, B., Nagy, K., Hultgren, S. J., Mendling, W., Wullt, B., Grabe, M., Wagenlehner, F. M., Cek, M. & other authors (2012). Update on biofilm infections in the urinary tract. World J Urol 30, 51-57.
34. Tielen, P., Narten, M., Rosin, N., Biegler, I., Haddad, I., Hogardt, M., Neubauer, R., Schobert, M., Wiehlmann, L. & Jahn, D. (2011). Genotypic and phenotypic characterization of Pseudomonas aeruginosa isolates from urinary tract infections. Int J Med Microbiol 301, 282-292.
35. Tunney, M. M., Jones, D. S. & Gorman, S. P. (1999). Biofilm and biofilm-related encrustation of urinary tract devices. Methods Enzymol 310, 558-566.
36. Wasfi, R., Abd El-Rahman, O. A., Mansour, L. E., Hanora, A. S., Hashem, A. M. & Ashour, M. S. (2012). Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections. Indian J Med Microbiol 30, 76-80.